Evaluation of the quinupristin/dalfopristin breakpoints for Enterococcus faecium.
Hammerum
Anette M
AM
Agersø
Yvonne
Y
Garcia-Migura
Lourdes
L
Mette Seyfarth
Anne
A
Porsbo
Lone J
LJ
Emborg
Hanne-Dorthe
HD
Bogø Jensen
Lars
L
D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D024901:Drug Resistance, Multiple, Bacterial; D016984:Enterococcus faecium / Q000187:drug effects*; D016908:Gram-Positive Bacterial Infections / Q000453:epidemiology / Q000382:microbiology / Q000662:veterinary*; D006801:Humans; D011201:Poultry Diseases / Q000453:epidemiology / Q000382:microbiology*; D013553:Swine Diseases / Q000453:epidemiology / Q000382:microbiology*; D014769:Virginiamycin / Q000008:administration & dosage*
D000900:Anti-Bacterial Agents; D014769:Virginiamycin; C062940:quinupristin-dalfopristin